<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="8985">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02989987</url>
  </required_header>
  <id_info>
    <org_study_id>SGBV1617</org_study_id>
    <nct_id>NCT02989987</nct_id>
  </id_info>
  <brief_title>NET for SGBV Survivors in Eastern DR Congo</brief_title>
  <official_title>Narrative Exposure Therapy for Survivors of Sexual and Gender Based Violence in Eastern DR Congo</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Konstanz</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Vivo international e.V.</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Konstanz</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Throughout the last 10 years Narrative Exposure Therapy (NET) has evolved as one of the most
      effective, culturally sensitive trauma interventions. In the present study the effectiveness
      of NET delivered by trained health personnel in a sample of survivors of sexual and gender
      based violence (SGBV) who suffer from Posttraumatic Stress Disorder (PTSD) will be assessed.
      Structured baseline, 3 and 6 month follow up interviews will be administered to assess the
      main outcome measures PTSD and shame. The trial will take place in Goma, DR Congo, where
      SGBV and its sequelae has been a major problem.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Participants will be recruited through local NGOs and eligible clients randomized to the
      treatment (NET; app. N=80) or treatment-as-usual control (app. N=80) group, respectively. At
      baseline, 3-month and 6-month post-treatment, sociodemographic data, trauma exposure - esp.
      SGBV, PTSD, dissociation, shame, functionality and depression will be assessed in a
      structured interview. The interviews will be conducted by blind Congolese psychological
      interviewers after an intensive 3-weeks training and continuous supervision.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">February 2018</completion_date>
  <primary_completion_date type="Anticipated">August 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single Blind (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>PSS-I: Posttraumatic Stress Disorder symptom severity (sumscore and diagnosis)</measure>
    <time_frame>Change from baseline to 3 and 6 months post treatment</time_frame>
    <description>PTSD Symptom Scale - Interview (PSS-I; Foa &amp; Tolin, 2000)</description>
  </primary_outcome>
  <primary_outcome>
    <measure>SVQ: Severity of shame (sumscore)</measure>
    <time_frame>Change from baseline to 3 and 6 months post treatment</time_frame>
    <description>Shame Variability Questionnaire (Brown, Rizvi &amp; Linehan, unpublished)</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>ShutD: Severity of Shutdown Dissociation Symptoms (sumscore)</measure>
    <time_frame>Change from baseline to 3 and 6 months post treatment</time_frame>
    <description>Shutdown Dissociation Scale (Schalinski et al., 2015)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>PHQ: Depression symptom severity (sumscore)</measure>
    <time_frame>Change in 3 and 6 months post treatment</time_frame>
    <description>Patient Health Questionnaire - 9 (PHQ-9; Kroenke &amp; Spitzer, 2002)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Functionality (sumscore)</measure>
    <time_frame>3 and 6 months post treatment</time_frame>
    <description>Local Functionality Index (LFI; Bass et al., 2013)</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">160</enrollment>
  <condition>Posttraumatic Stress Disorder</condition>
  <condition>Shame</condition>
  <arm_group>
    <arm_group_label>Narrative Exposure Therapy</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>According to the NET manual (one lifeline session and 7 exposure sessions; see Schauer et al. 2011).</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment-as-usual</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Social support (provided on demand)</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Narrative Exposure Therapy</intervention_name>
    <arm_group_label>Narrative Exposure Therapy</arm_group_label>
    <other_name>NET</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Social Support</intervention_name>
    <description>A local counselors provides social support on demand.</description>
    <arm_group_label>Treatment-as-usual</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  SGBV survivors (event happened more than 4 weeks ago)

          -  PTSD diagnosis (DSM-5)

        Exclusion Criteria:

          -  Acute psychosis

          -  Signs of cerebro-organic disease

          -  Acute drug or alcohol intoxication
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University of Konstanz</name>
      <address>
        <city>Konstanz</city>
        <state>BW</state>
        <zip>78464</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Anke Koebach, Dr.</last_name>
      <phone>07531884626</phone>
      <email>anke.koebach@uni-konstanz.de</email>
    </contact>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <reference>
    <citation>Schauer, M., Schauer, M., Neuner, F., &amp; Elbert, T. (2011). Narrative exposure therapy: A short-term treatment for traumatic stress disorders. Hogrefe Publishing.</citation>
  </reference>
  <verification_date>December 2016</verification_date>
  <lastchanged_date>December 7, 2016</lastchanged_date>
  <firstreceived_date>December 6, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Konstanz</investigator_affiliation>
    <investigator_full_name>Anke KÃ¶bach</investigator_full_name>
    <investigator_title>Postdoctoral Researcher</investigator_title>
  </responsible_party>
  <keyword>PTSD</keyword>
  <keyword>Shame</keyword>
  <keyword>Narrative Exposure Therapy</keyword>
  <keyword>Sexual and gender based violence (SGBV)</keyword>
  <keyword>DR Congo</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Stress Disorders, Post-Traumatic</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
